(Q52194850)

26 April 2018

title

Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline and fluvoxamine. II. The elevated plus-maze. (English)

1 reference

26 April 2018

1 reference

1 reference

Rodgers RJ

1

1 reference

26 April 2018

Cutler MG

series ordinal

2

1 reference

26 April 2018

Jackson JE

series ordinal

3

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 May 1997

1 reference

26 April 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

26 April 2018

volume

57

1 reference

26 April 2018

page(s)

127-136

1 reference

26 April 2018

issue

1-2

1 reference

26 April 2018

The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Attenuation of antipredator defensive behavior in rats following chronic treatment with imipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

The effects of chronic antidepressant treatment in an animal model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Fear-enhanced acoustic startle is not attenuated by acute or chronic imipramine treatment in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha 2-adrenoceptor mediation.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Anxiolytic effects of CCK-B antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Exploration of mice in a black and white test box: validation as a model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Ultrasonic vocalization in response to unavoidable aversive stimuli in rats: effects of benzodiazepines.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Behavioral interactions of fluoxetine and other 5-hydroxytryptamine uptake inhibitors with ethanol in tests of anxiety, locomotion and exploration.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Chronic treatment with imipramine does not reverse the effects of 3 anxiogenic compounds in a test of anxiety in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

SSRIs in anxious-agitated depression: a post-hoc analysis of 279 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Effects of acute and chronic imipramine administration on conflict behavior in the rat: a potential "animal model" for the study of panic disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Effects of acute and chronic administration of the antidepressants, imipramine, phenelzine and mianserin, on the social behaviour of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Predictive validity of the potentiated startle response as a behavioral model for anxiolytic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Profiles of the antipanic compounds, triazolobenzodiazepines and phenelzine, in two animal tests of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Major depression and generalized anxiety disorder. Same genes, (partly) different environments?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Comparison of anti-conflict drug effects in three experimental animal models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Anxiolytic-like effect of paroxetine in a rat social interaction test

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

The use of a plus-maze to measure anxiety in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Two tests in rats for antianxiety effect of clinically anxiety attenuating antidepressants.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Panic attacks. A neurochemical overview of models and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. A cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Can anti-panic drugs antagonise the anxiety produced in the rat by drugs acting at the GABA-benzodiazepine receptor complex?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Chronic mianserin or eltoprazine treatment in rats: effects on the elevated plus-maze test and on limbic 5-HT2C receptor levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Tricyclic antidepressants in the treatment of panic and anxiety disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Anxiogenic stimuli in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Differences in fear motivated behaviors among inbred mouse strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

A fully automated light/dark apparatus useful for comparing anxiolytic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900134-7

7 January 2021

10.1016/S0091-3057(96)00134-7

Identifiers

DOI

1 reference

26 April 2018

PubMed ID

9164563

1 reference

26 April 2018